ORAL TOLVAPTAN TABLETS IN SUBJECTS HOSPITALIZED WITH WORSENING CHF

因心力衰竭恶化住院的患者口服托伐普坦片

• 批准号: 7377518
• 负责人: KIRKWOOD F ADAMS
• 金额: $ 0.02万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377518
• 关键词: ORAL; TOLVAPTAN; TABLETS; SUBJECTS; HOSPITALIZED

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The reason for this study is to find out the potential benefits and safety of tolvaptam.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子弹和调查员（PI）可能已经从其他NIH来源获得了主要资金，因此可以在其他清晰的条目中代表。列出的机构适用于该中心，这不一定是调查员的机构。这项研究的原因是要找出Tolvaptam的潜在益处和安全性。